Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial

Author:

Gwee AmandaORCID,Steer Andrew,Phongluxa Khampheng,Luangphaxay Chanthaly,Senggnam Khanpaseuth,Philavanh Ammala,Lei Alice,Martinez April,Huang Shan,McWhinney Brett,Ungerer Jacobus,Duffull Stephen,Yang Wenyu,Zhu XiaoORCID,Coghlan Ben

Publisher

Elsevier BV

Reference36 articles.

1. Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in the Gambia;Dabira;Lancet Infect Dis,2022

2. WHO informal consultation on a framework for scabies control,2019

3. Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases,2022

4. The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015;Karimkhani;Lancet Infect Dis,2017

5. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis;Ottesen;N Engl J Med,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3